The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial-Reference-Cited by-同舟云学术

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

Published:2013-09 Issue:3 Volume:190 Page:857-862
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Gontero Paolo¹,Oderda Marco¹,Mehnert Anja²,Gurioli Alberto¹,Marson Francesco¹,Lucca Ilaria¹,Rink Michael³,Schmid Marianne³,Kluth Luis A.³,Pappagallo Giovanni⁴,Sogni Filippo⁵,Sanguedolce Francesco⁶,Schiavina Riccardo⁶,Martorana Giuseppe⁶,Shariat Shahrokh F.⁷,Chun Felix³

Affiliation:

1. Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy

2. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

3. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

4. Oncology Unit, Noale Hospital, Noale, Italy

5. Department of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy

6. Department of Urology, University of Bologna, Bologna, Italy

7. Department of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

2. The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer;Gontero;Eur Urol,2010

3. Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials;Shelley;BJU Int,2004

4. Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC);Gontero;Eur Urol,2004

5. Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder;Dalbagni;J Clin Oncol,2006

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer;Expert Opinion on Pharmacotherapy;2023-10-19

3. Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial;European Urology Open Science;2023-10

4. Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer;Cancers;2023-07-24

5. Calidad de vida en pacientes con tumor vesical no músculo-invasivo sometidos a tratamiento adyuvante intravesical;Actas Urológicas Españolas;2023-07